Tampus, Evabel .
HRN: 25-04-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CEFUROXIME 1.5GM (VIAL)
06/08/2024
06/08/2024
IVT
1.5g
On Call To OR
AUB Secondary To Myoma Subserous
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes